Novel TPO receptor agonist TA-316 contributes to platelet biogenesis from human iPS cells.

Aihara, Ayako; Koike, Tomo; Abe, Natsuki; Nakamura, Sou; Sawaguchi, Akira; Nakamura, Takanori; Sugimoto, Naoshi; Nakauchi, Hiromitsu; Nishino, Taito; Eto, Koji

Aihara, Ayako; Koike, Tomo; Abe, Natsuki; Nakamura, Sou; Sawaguchi, Akira; Nakamura, Takanori; Sugimoto, Naoshi; Nakauchi, Hiromitsu; Nishino, Taito; Eto, Koji.

Afiliação

Aihara A; Biological Research Laboratories, Nissan Chemical Industries Ltd., Saitama, Japan.
Koike T; Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Abe N; Biological Research Laboratories, Nissan Chemical Industries Ltd., Saitama, Japan.
Nakamura S; Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Sawaguchi A; Department of Anatomy, Miyazaki University Faculty of Medicine, Miyazaki, Japan.
Nakamura T; Biological Research Laboratories, Nissan Chemical Industries Ltd., Saitama, Japan.
Sugimoto N; Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Nakauchi H; Division of Stem Cell Therapy, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; and.
Nishino T; Biological Research Laboratories, Nissan Chemical Industries Ltd., Saitama, Japan.
Eto K; Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.

Blood Adv ; 1(7): 468-476, 2017 Feb 28.

Article em En | MEDLINE | ID: mdl-29296963

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Blood Adv Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google